Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Study of Longitudinal Monitoring in Treated Stage III-IV Lung Cancer Patients by Circulating Tumor DNA

NCT03664843 is registered in ClinicalTrials.gov with First Hospital of Shijiazhuang City as lead sponsor.

NCT NCT03664843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03664843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Study of Longitudinal Monitoring in Treated Stage III-IV Lung Cancer Patients by Circulating Tumor DNA
Lead sponsor
First Hospital of Shijiazhuang City
Phase
Observational
Overall status
Unknown status
Start date
November 9, 2018
Completion date
September 1, 2020
Enrollment
120 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, lung neoplasm, non-small cell lung cancer